Research has shown overexpression of HMGA2 in a variety of cancers [e.g., colorectal cancer (CRC), liver cancer, breast cancer (BC), and uterine leiomyomas], suggesting an essential role in tumor development and invasion (17–20). This evidence concerns the gene HMGA2 and colorectal cancer.